Leading AI Vendors AZmed, CoLumbo, Lucida Medical, Nicolab, Radiobotics, Therapixel, and Us2.ai Join as Launch Partners alongside Harrison.ai native apps
Harrison.ai announced the Harrison.ai Open Platform, a new paradigm that eliminates platform fees and enables single-integration access to multiple AI vendors. Built on three core principles – zero markup, radically open architecture, and customer ROI first – the platform fundamentally shifts how healthcare organizations access and deploy medical imaging AI by eliminating traditional platform fees that can be 30-60% or even higher.
"Our partnership with Harrison.ai represents a shared commitment to delivering next-generation healthcare solutions. Us2.AI brings precision, speed, and ease to echocardiography, empowering clinicians to provide optimal cardiac care.” – Daniel Ishak, Commercial Director at Us2.ai
The Harrison.ai Open Platform is available with Harrison.ai's newest CT chest product as well as the existing Chest X-Ray and CT Brain native apps. Seven leading AI vendors have also joined as launch partners that will be available in 2026: AZmed (fracture detection), CoLumbo (lumbar spine MRI), Lucida Medical (prostate cancer), Nicolab (stroke), Radiobotics (fracture detection), Therapixel (mammography), and Us2.ai (echocardiography).
About Harrison.ai
Harrison.ai is a global healthcare technology company that enhances clinician capacity and patient care through AI automation. Clinician-led and patient-first, our suite of solutions supports earlier, more accurate diagnoses and seamlessly integrates into clinical workflows.
Harrison.ai solutions are available in 40+ countries and to half of all Australian radiologists. They are clinically deployed at 1,000+ customer sites globally, including 40+ NHS Trusts and all public emergency departments in Hong Kong. With 3,400+ clinicians using our tools, Harrison.ai has impacted 6.7 million patients' lives to date.
For more information, visit Harrison.ai.